MAP Kinase-Activating Death Domain (CT) Blocking Peptide
- -
- -
Antibody DetailsProduct DetailsReactive Species Human Product Concentration 0.2 mg/ml Amino Acid Location This peptide sequence is located at amino acids 1570 to 1588 of Human MADD protein. Formulation This peptide is formulated in PBS pH 7.2 (0.01 M Sodium Phosphate, 0.13 M NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide. Storage and Handling Store this peptide in working aliquots at -20°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles. Country of Origin USA Shipping Next Day Ambient Amino Acid Sequence 19 amino acids near the carboxy terminus of human MADD. Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change. DescriptionBackground MAP Kinase-Activating Death Domain (CT) peptide is applicable as a control peptide for blocking antibody binding in Western blotting. References & Citations1. Milbrandt J, de Sauvage FJ, Fahrner TJ, et al. Persephin, a novel neurotrophic factor related to GDNF and neurturin. Neuron 1998;20:245-253.
2. Nomeclature Committee. Nomeclature of GPI-linked receptors for the GDNF ligand family. GFRa. Neuron 1997: 19:485.
3. Jing S. Yu Y, Fang M, Hu Z, Holst PL , Boone T, Delaney J. Schultz H, Zhou R, Fox GM. GFRα-2 and GFRα-3 are two new receptors for ligands of the DGNF family. J Biol Chem 1997; 272:33111-33117
4. Baloh RH, Gorodinsky A, Golden JP, Tansey MG, Keck CL, Popescu NC , Johnson EM Jr, Milbrandt J. GFRα3 is an orphan member of the GDNF/neurturin/persephin receptor family. Proc Natl Acad Sci USA 1998;95:5801-5806. |
Related Products
- -
- -
Prod No. | Description |
|---|---|
M1021 | |
M1207 |
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
